Unannounced phone-based pill counts for monitoring antiretroviral medication adherence in South Africa.

IF 1.7 4区 医学 Q3 INFECTIOUS DISEASES HIV Research & Clinical Practice Pub Date : 2023-12-01 Epub Date: 2023-11-02
Seth Kalichman, Ellen Banas, Bruno Shkembi, Moira Kalichman, Catherine Mathews
{"title":"Unannounced phone-based pill counts for monitoring antiretroviral medication adherence in South Africa.","authors":"Seth Kalichman, Ellen Banas, Bruno Shkembi, Moira Kalichman, Catherine Mathews","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Unannounced phone-based pill counts (UPC) are an objective measure of medication adherence that may be used in resource limited settings. The current study reports the feasibility and validity of UPC for monitoring antiretroviral therapy (ART) adherence among people living with HIV in South Africa. People living with HIV (<i>N</i> = 434) in an economically impoverished township and receiving ART for at least 3-months completed: two UPC in a one-month period; measures of clinic and medication experiences; and provided blood samples for HIV viral load and CD4 testing. Analyses compared two methods for managing values of over-dosing (> 100%), specifically censoring values to 100% (> 100% = 100%) vs. subtracting over-dosing from two months of perfect adherence (200% - > 100% value).</p><p><strong>Results: </strong>Findings showed that two UPC calls were successfully completed with 91% of participants in a one-month period. The average number of call attempts needed to reach participants was 2.4. Results showed that lower UPC adherence was significantly associated with male gender, alcohol use, higher HIV viral loads, lower CD4 cell counts, running out of ART, and intentionally not taking ART. Comparisons of methods for adjusting over-dosing found subtraction yielding a better representation of the data than censoring.</p><p><strong>Conclusions: </strong>UPC were demonstrated feasible and valid with patients receiving ART in a resource limited setting and offers a viable method for objectively measuring ART adherence in these settings.</p>","PeriodicalId":13165,"journal":{"name":"HIV Research & Clinical Practice","volume":"24 1","pages":"2269677"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Research & Clinical Practice","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Unannounced phone-based pill counts (UPC) are an objective measure of medication adherence that may be used in resource limited settings. The current study reports the feasibility and validity of UPC for monitoring antiretroviral therapy (ART) adherence among people living with HIV in South Africa. People living with HIV (N = 434) in an economically impoverished township and receiving ART for at least 3-months completed: two UPC in a one-month period; measures of clinic and medication experiences; and provided blood samples for HIV viral load and CD4 testing. Analyses compared two methods for managing values of over-dosing (> 100%), specifically censoring values to 100% (> 100% = 100%) vs. subtracting over-dosing from two months of perfect adherence (200% - > 100% value).

Results: Findings showed that two UPC calls were successfully completed with 91% of participants in a one-month period. The average number of call attempts needed to reach participants was 2.4. Results showed that lower UPC adherence was significantly associated with male gender, alcohol use, higher HIV viral loads, lower CD4 cell counts, running out of ART, and intentionally not taking ART. Comparisons of methods for adjusting over-dosing found subtraction yielding a better representation of the data than censoring.

Conclusions: UPC were demonstrated feasible and valid with patients receiving ART in a resource limited setting and offers a viable method for objectively measuring ART adherence in these settings.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
南非监测抗逆转录病毒药物依从性的未公布的基于电话的药丸计数。
背景:未公布的基于电话的药丸计数(UPC)是一种衡量药物依从性的客观指标,可用于资源有限的环境。目前的研究报告了UPC监测南非艾滋病毒感染者抗逆转录病毒治疗(ART)依从性的可行性和有效性。艾滋病毒感染者(N = 434),并接受至少3个月的抗逆转录病毒治疗:一个月内两次UPC;临床和用药经验的衡量标准;并提供了用于HIV病毒载量和CD4检测的血液样本。分析比较了两种管理过量给药(>100%)值的方法,特别是将值审查为100%(>100%=100%),而从两个月的完全依从性(200%->100%值)中减去过量给药。结果:研究结果显示,91%的参与者在一个月内成功完成了两次UPC呼叫。联系参与者所需的平均呼叫尝试次数为2.4次。结果显示,UPC依从性较低与男性、饮酒、HIV病毒载量较高、CD4细胞计数较低、抗逆转录病毒疗法用尽和故意不服用抗逆转录病毒治疗显著相关。对调整过量给药方法的比较发现,减法比删截更能代表数据。结论:UPC在资源有限的环境中对接受ART的患者是可行和有效的,并为客观测量这些环境中的ART依从性提供了一种可行的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.90
自引率
6.20%
发文量
15
期刊最新文献
A closer look: factors impacting HIV durable viral suppression among a cohort of clinic attendees in Trinidad & Tobago. Evaluation of the effect of 48 weeks of BIC/F/TAF and DRV/c/F/TAF on platelet function in the context of rapid ART start. 'It is scary to pause treatment': perspectives on HIV cure-related research and analytical treatment interruptions from women diagnosed during acute HIV in Durban, South Africa. Impacts of a multipronged initiative with community HIV clinics to support retention and re-engagement in HIV care. Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1